Synopsis
Synopsis
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
API
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. 10-(3-dimethylamino-2-methylpropyl)phenothiazine-2-carbonitrile
2. Cyamamazine
3. Cyamemazine Monohydrochloride
4. Cyamepromazine
1. Cyamepromazine
2. 3546-03-0
3. Tercian
4. Cianatil
5. Cyamemazin
6. Kyamepromazine
7. Cyamemazine [inn]
8. Th 2602
9. Rp-7204
10. Kyamepromazin
11. 7204 Rp
12. Rp 7204
13. F.i. 6229
14. A2jgv5cnu4
15. 10-(3-(dimethylamino)-2-methylpropyl)phenothiazine-2-carbonitrile
16. 10-(3-(dimethylamino)-2-methylpropyl)-10h-phenothiazine-2-carbonitrile
17. 10-[3-(dimethylamino)-2-methylpropyl]-10h-phenothiazine-2-carbonitrile
18. 7204 R.e.
19. 10-[3-(dimethylamino)-2-methylpropyl]phenothiazine-2-carbonitrile
20. Cyamemazine (inn)
21. Fl-6229
22. Th-2602
23. Cyamepromezine
24. Ciamatil
25. Phenothiazine-2-carbonitrile, 10-(3-(dimethylamino)-2-methylpropyl)-
26. 10h-phenothiazine-2-carbonitrile, 10-(3-(dimethylamino)-2-methylpropyl)-
27. Ciamemazina
28. Cyamemazinum
29. 10h-phenothiazine-2-carbonitrile, 10-[3-(dimethylamino)-2-methylpropyl]-
30. Cyamemazinum [inn-latin]
31. Ciamemazina [inn-spanish]
32. Einecs 222-594-2
33. Unii-a2jgv5cnu4
34. Brn 0093261
35. Fi 6229
36. 10-(3-dimethylamino-2-methylpropyl)phenothiazine-2-carbonitrile
37. Cyamemazine [mi]
38. Gtpl84
39. Cyamemazine [mart.]
40. Cyamemazine [who-dd]
41. 4-27-00-04111 (beilstein Handbook Reference)
42. Schembl143041
43. Chembl2104153
44. Bdbm86057
45. Cyamemazine, >=98% (hplc)
46. Dtxsid80863190
47. Chebi:135379
48. Bcp07169
49. Cas_62865
50. Nsc_62865
51. Pdsp1_001282
52. Pdsp2_001266
53. Th2602
54. Akos030254703
55. Db09000
56. Hy-14264
57. Cs-0002964
58. Ft-0665239
59. Ft-0665240
60. D07307
61. L001155
62. Sr-01000945035
63. Q3008033
64. Sr-01000945035-1
65. 2-cyano-10-(3-[dimethylamino]-2-methyl-propyl)-phenothiazine
66. 10-[3-(dimethylamino)-2-methylpropyl]-10h-phenothiazine-2-carbonitrile #
Molecular Weight | 323.5 g/mol |
---|---|
Molecular Formula | C19H21N3S |
XLogP3 | 4.4 |
Hydrogen Bond Donor Count | 0 |
Hydrogen Bond Acceptor Count | 4 |
Rotatable Bond Count | 4 |
Exact Mass | 323.14561886 g/mol |
Monoisotopic Mass | 323.14561886 g/mol |
Topological Polar Surface Area | 55.6 Ų |
Heavy Atom Count | 23 |
Formal Charge | 0 |
Complexity | 443 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 1 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 1 |
N - Nervous system
N05 - Psycholeptics
N05A - Antipsychotics
N05AA - Phenothiazines with aliphatic side-chain
N05AA06 - Cyamemazine
Market Place
ABOUT THIS PAGE
48
PharmaCompass offers a list of Cyamemazine API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Cyamemazine manufacturer or Cyamemazine supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Cyamemazine manufacturer or Cyamemazine supplier.
PharmaCompass also assists you with knowing the Cyamemazine API Price utilized in the formulation of products. Cyamemazine API Price is not always fixed or binding as the Cyamemazine Price is obtained through a variety of data sources. The Cyamemazine Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Cyamemazine manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Cyamemazine, including repackagers and relabelers. The FDA regulates Cyamemazine manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Cyamemazine API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Cyamemazine manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Cyamemazine supplier is an individual or a company that provides Cyamemazine active pharmaceutical ingredient (API) or Cyamemazine finished formulations upon request. The Cyamemazine suppliers may include Cyamemazine API manufacturers, exporters, distributors and traders.
click here to find a list of Cyamemazine suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
Cyamemazine Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Cyamemazine GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Cyamemazine GMP manufacturer or Cyamemazine GMP API supplier for your needs.
A Cyamemazine CoA (Certificate of Analysis) is a formal document that attests to Cyamemazine's compliance with Cyamemazine specifications and serves as a tool for batch-level quality control.
Cyamemazine CoA mostly includes findings from lab analyses of a specific batch. For each Cyamemazine CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Cyamemazine may be tested according to a variety of international standards, such as European Pharmacopoeia (Cyamemazine EP), Cyamemazine JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Cyamemazine USP).